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Intramedullary tuberculomas are extremely rare, being 
present in approximately 2 of every 100,000 cases of 
tuberculosis and 2 of every 1000 cases of tuberculosis 
of the central nervous system.‘-* Infection with human 
immunodeficiency virus (HIV) increases the risk of tuber- 
culosis, which may occur at any stage of immunodefi- 
ciency. Extrapulmonary disease is more common in 
patients with HIV infection.5-s The authors believe that 
the following is the first report of an intramedullary tuber- 
culoma, associated with HIV infection, in a patient with 
disseminated multidrug-resistant tuberculosis. The 
patient’s neurologic condition improved after an anti- 
tuberculosis retreatment regimen that included isoniazid, 
pyrazinamide, amikacin, and ciprofloxacin. 
CASE REPORT 
The patient was a 26year-old white Portuguese man with 
a history of intravenous drug use; he was found to be 
seropositive for HIV-l in 1991. In July 1993, the patient 
was diagnosed with disseminated tuberculosis and was 
initially treated with rifampin, isoniazid, pyrazinamide, 
and ethambutol. Marked symptomatic improvement was 
noticed during the first 4 weeks of treatment, but there- 
after several relapses occurred, owing to poor compli- 
ance with therapy In January 1994, ciprofloxacin was 
substituted for ethambutol, because of the emergence of 
ethambutol resistance. In May 1994, the patient experi- 
enced a left cervicobrachialgia and progressive weakness, 
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numbness, and paresthesia of upper extremities with 
occasional urinary incontinence. 
In July 1994, the patient developed seizures, and com- 
puted tomography (CT) showed intracranial hypodense 
contrast-ring-enhancing mass lesions (Figure 1). Cerebral 
biopsy was not done. Antituberculosis therapy was con- 
tinued, and a 2-month course of pyrimethamine and sul- 
fadiazine was administered, with clinical improvement. In 
November 1994, CT was normal. 
In February 1995, the patient was hospitalized 
because of severe neck pain, progressive weakness, numb- 
ness, and paresthesia of both arms, more marked on the 
left. On physical examination, wasting was the only sig- 
nificant finding. Neurologic examination showed a fully 
alert, oriented, and cooperative patient. He complained of 
severe pain in the neck and marked tenderness was found 
on the cervical spine. There was prominent wasting of 
the intrinsic hand muscles and strength in the upper 
limbs was graded distally and proximally, as O/5 and 3/5, 
respectively, on the left; 3/5 and 4/5, respectively, on the 
right. Deep tendon reflexes were absent in the upper 
limbs, the left knee jerk was brisker, and extensor plan- 
tar reflex was present on the left. A marked decrease in 
sensation to pinprick and vibration was found from C2 
to Tl, bilaterally Joint position sense was impaired in the 
fingers. 
Ancillary tests showed a white blood cell count of 2.7 
X 109/L with 66% granulocytes and 20% lymphocytes. 
The serum alkaline phosphatase level was 171 U/L; the 
gamma glutamyltransferase level was 292 U/L; and the 
aspartate aminotransferase level was 87 U/L. The total 
bilirubin level was 2.4 mg/dL, and the conjugated biliru- 
bin level was 0.6 mg/dL. Blood cultures were positive for 
Mycobacterium tuberculosis. The patient’s total CD4 
lymphocyte count was 0.07 X lob/L. 
A skin test with five tuberculin units of purified pro- 
tein derivative (PPD) was negative. A cerebrospinal fluid 
(CSF) profile revealed an elevated protein level of 115 
mg/dL, with a glucose level of 46 mg/dL and a white 
blood cell count of 1 X lob/L, with 100% monocytes. 
164 
Intermedullary Tuberculoma / Barges et al 165 
Figure 3. T2-weighted MRI showing a hypointense lesion with edema. 
Figure 1. Axial cranial CT showing two nodular enhancing lesions with 
marked perifocal edema. The left temporal lobe shows a hypodense 
area, due to edema associated with a third lesion. 
Microscopic examination of stained specimens of the 
fluid showed no acid-fast bacilli, fungi, or other micro- 
organisms, and cultures were negative. Toxoplasma anti- 
body and cryptococcal antigen tests on CSF and sernm 
were negative. 
Chest radiography revealed bilateral apical scarring, 
similar to previous findings. A CT scan of the cervical 
spine revealed a widened cord from Cl to ~6. Magnetic 
resonance imaging (MRI) demonstrated a focal swelling 
of the cord in the cervical segment, due to the presence 
of an intramedullary nodular lesion at the level of C4, 
hyperintense in Tl-weighted MRI and with marked 
enhancement after intravenous gadolinium (Figure 2). In 
T2-weighted MRI, the lesion was hypointense, with asso- 
ciated hyperintensity above and below, indicating edema 
(Figure 3). 
The patient continued on antituberculous therapy, 
and amikacin was added. He also continued to receive 
Figure 2. Leff, A sagittal Tl-weighted MRI of the cervical spine, 
revealing a cord edema associated with a nodular hyperintense lesion 
at the C4 level. Right, Gadolinium-enhanced MRI of the cervical spine, 
revealing an enhancing homogeneous intramedullary lesion. 
Figure 4. MRI of the cervical spine, demonstrating the clear reduction 
of the dimensions and mass effect of the intramedullaty tuberculoma. 
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antiretroviral therapy and prophylaxis against Pneumo- 
cystis and toxoplasmosis. His condition improved gradu- 
ally, and on the seventh day of therapy the strength in the 
upper limbs was graded 3/5 (distally), 5/5 (proximally) on 
the left and 5/5 on the right; sensation was normal. The 
patient was discharged 4 weeks after admission, but he 
returned in May 1995 because paresthesia and weakness 
had worsened, despite good compliance with therapy 
(self-reporting). Sputum acid-fast stains were again posi- 
tive and cultures grew rifampin-resistant M. tuberculosis. 
Thoracic CT revealed cavitations on the apical left lung. 
A liver biopsy was performed. Histologic examination 
was normal, with a negative search for acid-fast bacilli 
(stain and culture). A 4-week course of steroids (pred- 
nisolone, 40 mg/d) was added to the current treatment, 
with improvement of the neurologic abnormalities. A 
repeat MRI, performed 3 months after the first, showed 
a clear reduction of the mass effect and dimensions of the 
lesion (Figure 4). The patient’s neurologic examination 
gradually improved, and he was discharged in June 1995. 
He had no complaints, and neurologic examination was 
normal, except for the presence of a brisker knee jerk and 
an extensor plantar response on the left. He completed 
18 months of retreatment regimen with isoniazid, pyraz- 
inamide, amikacin, and ciprofloxacin. On follow-up, 1 year 
later (June 1996) neurologic findings remained stable 
and all cultures and smears were negative. Additional MRI 
studies were not done. 
DISCUSSION 
The incidence of tuberculosis has increased in recent 
years, at least in part as a result of the ongoing worldwide 
epidemic of acquired immunodeficiency syndrome 
(AIDS). In addition, the occurrence of outbreaks caused 
by multidrug-resistant M. tuberculosis has become 
increasingly a matter of concern.6-9 The risk of progres- 
sion of tuberculosis may be greater in HIV-infected intra- 
venous drug users than in other HIV-infected 
populations. 8,9 Central nervous system tuberculosis is a 
rare entity affecting 0.5 to 2% of patients with systemic 
tuberculosis.3 The majority of the lesions are intracranial, 
with the ratio of intracranial to intramedullary lesions 
ranging from 2O:l to 4&l, depending on the series.‘,” 
Intramedullary spinal tuberculoma is a rare condi- 
tion. Only three cases have been documented in the lit- 
erature, since Lin’s review of the subject in 1960, with 105 
cases.‘s3s4 In agreement with previous reports, intra- 
medullary spinal tuberculoma seems to be a disease of 
relatively young patients and probably originates from 
hematogenous seeding from an extraneural focus (usually 
pulmonary or renal), or as a part of miliary tuberculosis9 
The uncommon involvement of the spinal cord compared 
to the brain, suggests that the location of these lesions is 
determined by the relative distribution of neural tissue 
within the nervous system, in conjunction with local fac- 
tors, such as blood flow, although other factors may be 
involved.1~3~10 
The patient discussed here is the first case reported 
in the literature of an intramedullary tuberculoma asso- 
ciated to multidrug-resistant disseminated tuberculosis, 
including intracerebral, and HIV infection. His presenta- 
tion was similar to that of cases reported in the pre-AIDS 
era,5 with motor and sensory deficits and, like many other 
patients, he had extraspinal tuberculosis, with culture- 
documented pulmonary disease and presumed cerebral 
tuberculomas. It is possible that the brain abscesses seen 
during an earlier admission were due to toxoplasmosis, 
despite negative serology, as he improved clinically and 
radiographically after a course of sulfadiazine and 
pyrimethamine. The authors emphasize the difficulty in 
differentiating these lesions from those of other etiolo- 
gies. l1 However, it is known that a strong correlation 
exists between them and disseminated tuberculosis.1-5,12~13 
In this case, there was a disseminated tuberculosis with 
a protracted and relapsing symptomatology and persis- 
tently positive cultures, due to noncompliance and drug 
(ethambutol and rifampin) resistance.13-I5 In spite of the 
lack of a biopsy, the clinical and neuroradiologic improve- 
ment observed with adequate antituberculous therapy 
strongly suggests a tuberculous etiology.11~13~14 The relative 
roles of steroids and antituberculous therapy in the 
improvement seen on the second MRI remain uncertain. 
Intramedullary tuberculoma, although a rare entity, 
must be considered in the differential diagnosis of sub- 
acute spinal cord compression, particularly in patients with 
evidence of extraneural tuberculous disease.1-5~7~9,11~13-1s 
The advent of MRI may facilitate the diagnosis of an 
intramedullary mass consistent with tuberculoma.12,13 
Medical therapy remains the mainstay of treatment, but 
when confronted with a progressing neurologic deficit, 
the neurosurgeon may need to remove the lesion.1.7-‘1,15~‘6 
In patients managed with appropriate therapy, the prog- 
nosis for neurologic improvement is good.lm3 Although 
results of treatment of multidrug-resistant tuberculosis in 
HIV-infected patients are usually poor, with high rates of 
treatment failure and mortality,13 vigorous and appropri- 
ate antituberculous treatment is always worth trying. 
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